Charlie McDermott
North America, California, United States
Description
Charlie McDermott, Chairman, President & Chief Executive Officer at Primmune Therapeutics.
Investor Profile
Charlie McDermott has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care.
Stage Focus
- Series A (50%)
- Seed (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
